Related Experiment Videos
Anti-sense oligodeoxynucleotides--promises and pitfalls
1Department of Medicine, Columbia University Comprehensive Cancer Center, New York, NY 10032.
Leukemia
|October 1, 1992
Summary
Oligodeoxynucleotides show promise for cancer therapy due to specific mRNA targeting. However, challenges like nuclease sensitivity and delivery issues hinder widespread use, requiring further research for therapeutic application.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Therapeutics
Background:
- Oligodeoxynucleotides exhibit high specificity for target mRNA.
- This characteristic suggests potential as anticancer therapeutic agents.
Purpose of the Study:
- To review current information on obstacles to oligodeoxynucleotide therapeutic use.
- To address challenges impacting the application of antisense technology in cancer treatment.
Main Methods:
- Literature review of antisense experiments.
- Analysis of challenges including nuclease sensitivity, specificity, target selection, cellular pharmacology, pharmacokinetics, and dosing.
Main Results:
- Numerous successful antisense experiments are documented.
- Significant obstacles remain for widespread therapeutic application.
- Key challenges include nuclease sensitivity, non-sequence specificity, and target identification.
Conclusions:
- Further research is needed to overcome current limitations.
- Understanding cellular pharmacology, pharmacokinetics, and dosing is crucial.
- Addressing these issues will facilitate the advancement of oligodeoxynucleotides as cancer therapeutics.